Bivalent Poliomyelitis Vaccine Live 10 dose vial (with a suitable dropper)

• Country: Sri Lanka
• Summary: Bivalent Poliomyelitis Vaccine Live 10 dose vial (with a suitable dropper)
• LKT Ref No: 116428950
• Deadline: 30 Apr 2025
• Financier: Self Financed
• Purchaser Ownership: Public
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: DHS/P/WW/341/26
• Purchaser's Detail:

Purchaser : STATE PHARMACEUTICALS CORPORATION OF SRI LANKA
No.75, Sir Baron Jayathilake Mawatha, Colombo 01, Sri Lanka. Telephone :+94 (0)11 2320356-9, Fax :+94 (0)11 2447118
Email :chairman@spc.lk

• Description:
• Bivalent Poliomyelitis Vaccine Live 10 dose vial (with a suitable dropper) Bivalent Poliomyelitis Vaccine Live Oral (bOPV)10 dose vial Bivalent Poliomyelitis Vaccine Live BP,EP or USP Liquid stabilized preparation of live attenuated poliomyelitis virus of the Sabin strains type 1 and type 3. Each immunizing dose of vaccine should contain not less than 10 6 TCID50 for type 1 and 10 5.8 TCID50 for type 3 (should conform to the formulation of ratio of 10:6 for vaccine virus sero type 1 and 3 respectively). One immunizing dose should be contained preferably in two drops. i.Offers should be only from vaccine suppliers recommended by World Health Organization (WHO) for bulk purchase for the U.N. Agencies. ii.The product should be from fresh stocks and each consignment should be prepared preferably from a single batch. Each batch should accompany a certificate of analysis,lot release certificate issued by laboratory accredited by National Control Authority and Summary Protocol of vaccine production and quality control test data should be submitted for protocol review. iii.Each consignment should have a minimu m remaining shelf life of 75% at the time of r eceiving the consignment at MSD. iv.The vaccine should also comply with the general requirements for vaccines in the BP,EP or USP. v.The vaccine should meet the most recent requirements of WHO when tested by the methods outlined by WHO. vi.Cold chain monitors or WHO recommended other cold chain monitoring device should be included in each pack during delivery and the cold chain should be maintained during storage, transport and delivery of vaccines. vii.The vaccine should be protected from light and should be stored at a temperature - 20'C. 65,000 vials 35,000 vials/ August 2026 30,000 Vials/ November 2026 2 viii.Each vial should be labeled accordingly indicating both date of manufacture and expiry. ix.Must be a WHO prequalified product. x.Each vial should be provided with a suitable dropper. xi.Each vial should contain a suitable vaccine vial monitor. xii.Chief Epidemiologist should be informed two weeks prior to the arrival of vaccine
• Documents:

 Tender Notice